Russ Rahimtoola

Russ Rahimtoola is a seasoned professional in the biopharmaceutical and healthcare industries with extensive experience in national accounts and market access. Currently serving as Senior National Account Director for Rare Disease at PTC Therapeutics, Inc. since 2017, Russ focuses on developing novel treatments for serious disorders. Prior roles include Senior Director of Market Access at Bioventus, Senior National Account Executive at Endo Pharmaceuticals, and Senior Director of Market Access & National Accounts at Oscient Pharmaceuticals. Additional experience includes a National Account Director position at Sunovion Pharmaceuticals and earlier roles at Solvay and Deutsche Bank. Educational qualifications encompass a Bachelor of Applied Science from San Diego State University, a Master of Arts in Economics from UC San Diego, and an Executive program in Health Care Administration from UCLA Anderson School of Management.